Altinoz, M. A. Et Al. 2022. Combining Locoregional CAR-T Cells, Autologous + Allogeneic Tumor Lysate Vaccination and Levamisole in Treatment of Glioblastoma.. Immunopharmacology and immunotoxicology , vol.44 , 797-808.

Altinoz, M. A., Ozpinar, A., Hacker, E., & Ozpinar, A., (2022). Combining Locoregional CAR-T Cells, Autologous + Allogeneic Tumor Lysate Vaccination and Levamisole in Treatment of Glioblastoma.. Immunopharmacology and immunotoxicology , vol.44, 797-808.

Altinoz, Meric Et Al. "Combining Locoregional CAR-T Cells, Autologous + Allogeneic Tumor Lysate Vaccination and Levamisole in Treatment of Glioblastoma.," Immunopharmacology and immunotoxicology , vol.44, 797-808, 2022

Altinoz, Meric A. Et Al. "Combining Locoregional CAR-T Cells, Autologous + Allogeneic Tumor Lysate Vaccination and Levamisole in Treatment of Glioblastoma.." Immunopharmacology and immunotoxicology , vol.44, pp.797-808, 2022

Altinoz, M. A. Et Al. (2022) . "Combining Locoregional CAR-T Cells, Autologous + Allogeneic Tumor Lysate Vaccination and Levamisole in Treatment of Glioblastoma.." Immunopharmacology and immunotoxicology , vol.44, pp.797-808.

@article{article, author={Meric A Altinoz Et Al. }, title={Combining Locoregional CAR-T Cells, Autologous + Allogeneic Tumor Lysate Vaccination and Levamisole in Treatment of Glioblastoma.}, journal={Immunopharmacology and immunotoxicology}, year=2022, pages={797-808} }